BIOGEN INC. is 17.1x more valuable than aTYR PHARMA INC by market capitalization ($28.68 B vs $1.67 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | LIFE | BIIB |
|---|---|---|
| Market cap | $1.67 B | $28.68 B |
| US-listed rank | #2240 | #476 |
| Revenue (latest FY) | $190.00K | $9.89B |
| Net income (latest FY) | -$74.12M | $1.29B |
| Net margin | -39009.5% | 13.1% |
| P/E (trailing FY) | - | 22.2 |
| SEC filings | 720 | 2,690 |
BIOGEN INC. is 17.1x more valuable than aTYR PHARMA INC by market capitalization ($28.68 B vs $1.67 B).
In their latest fiscal years, aTYR PHARMA INC reported $190.00K in revenue while BIOGEN INC. reported $9.89B.
Full pages: aTYR PHARMA INC and BIOGEN INC., or browse the full rankings.